المؤلفون: Temkin SM; Clinical Research, Office on Research for Women's Health, National Institutes of Health, Bethesda, MD, USA., Chapman-Davis E; Obstetrics and Gynecology, Weill Cornell Medical College, New York, NY, USA., Nair N; Louisiana State University Health Sciences Center, New Orleans, LA, USA., Cohn DE; Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA., Hines JF; WellStar Medical Group, Smyrna, GA, USA., Kohn EC; Gynecologic Cancer Therapeutics, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD, USA., Blank SV; Gynecologic Oncology for the Mount Sinai Health System, Icahn School of Medicine at Mount Sinai and the Blavatnik Family Women's Health Research Institute, New York, NY, USA. Electronic address: Stephanie.Blank@mountsinai.org.

المصدر: Gynecologic oncology [Gynecol Oncol] 2022 Mar; Vol. 164 (3), pp. 473-480. Date of Electronic Publication: 2022 Jan 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Genital Neoplasms, Female*/therapy , Workplace*, Female ; Humans ; Male ; Surveys and Questionnaires

المؤلفون: Lee YC; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Wang L; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada., Kohn EC; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland., Rubinstein L; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland., Ivy SP; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland., Harris PJ; Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, Maryland., Lheureux S; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

المصدر: Cancer [Cancer] 2020 May 15; Vol. 126 (10), pp. 2139-2145. Date of Electronic Publication: 2020 Feb 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents/*adverse effects , Drug-Related Side Effects and Adverse Reactions/*epidemiology , Genital Neoplasms, Female/*drug therapy, Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/therapeutic use ; Clinical Trials, Phase I as Topic ; Databases, Factual ; Drug-Related Side Effects and Adverse Reactions/classification ; Female ; Humans ; Middle Aged ; National Cancer Institute (U.S.) ; Retrospective Studies ; United States ; Young Adult

المؤلفون: Bagnoli M; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy. marina.bagnoli@istitutotumori.mi.it., Shi TY; Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. tyshi80@163.com., Gourley C; University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh EH4 2XU, UK. Charlie.Gourley@ed.ac.uk., Speiser P; Department of Gynaecologic Oncology, Medical University Vienna, General Hospital Vienna, 1090 Wien, Austria. pspeis54@gmail.com., Reuss A; Coordinating Center for Clinical Trials, at the Philipps-University of Marburg, 35043 Marburg, Germany. alexander.reuss@kks.uni-marburg.de., Nijman HW; Department of Obstetrics & Gynecology, University Medical Center Groningen, 9700 RB Groningen, The Netherlands. h.w.nijman@umcg.nl., Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands. c.l.creutzberg@lumc.nl., Scholl S; Department of Drug Development and Innovation, Institut Curie, 75005 Paris, France. suzy.scholl@curie.fr., Negrouk A; European Organisation for Research and Treatment of Cancer (EORTC), 1200 Brussels, Belgium. anastassia.negrouk@eortc.org., Brady MF; Department of Biostatistics & Bioinformatics, Roswell Park Cancer Institute, Buffalo, NY 14203, USA. brady@gogstats.org., Hasegawa K; Department of Gynecologic Oncology, Saitama Medical University International Medical Center, Saitama 1397-1, Japan. koseih@gmail.com., Oda K; Department of Obstetrics and Gynecology, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan. katsutoshi-tky@umin.ac.jp., McNeish IA; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London SW7 2AZ, UK. i.mcneish@imperial.ac.uk., Kohn EC; Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Rockville, MD 20852, USA. kohne@mail.nih.gov., Oza AM; Department of Medicine, Division of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON M5G 2M9, Canada. Amit.Oza@uhn.ca., MacKay H; Division of Medical Oncology, University of Toronto/Sunnybrook Odette Cancer Centre, Toronto, ON M4N 3M5, Canada. helen.mackay@sunnybrook.ca., Millan D; Department of Pathology, Queen Elizabeth University Hospital, Glasgow G51 4TR, UK. david.millan59@btinternet.com., Bennett K; Gynecologic Cancer InterGroup, Operations, Kingston, ON K7K-7A6, Canada. gcigopsasst@gmail.com., Scott C; Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria 3052, Australia. scottc@wehi.edu.au., Mezzanzanica D; Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milan, Italy. delia.mezzanzanica@istitutotumori.mi.it.

المصدر: Cells [Cells] 2019 Feb 26; Vol. 8 (3). Date of Electronic Publication: 2019 Feb 26.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Print ISSN: 2073-4409 (Print) Linking ISSN: 20734409 NLM ISO Abbreviation: Cells Subsets: MEDLINE

مواضيع طبية MeSH: Consensus* , Translational Research, Biomedical*, Genital Neoplasms, Female/*pathology, Biomarkers, Tumor/metabolism ; Clinical Trials as Topic ; Female ; Humans ; Precision Medicine

المؤلفون: Annunziata CM; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States. Electronic address: annunzic@mail.nih.gov., Kohn EC; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

المصدر: Gynecologic oncology [Gynecol Oncol] 2018 Feb; Vol. 148 (2), pp. 393-402. Date of Electronic Publication: 2017 Dec 06.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Clinical Trials as Topic*, Antineoplastic Agents/*therapeutic use , Genital Neoplasms, Female/*drug therapy, Biomarkers, Tumor/metabolism ; Female ; Forecasting ; Humans

المؤلفون: Lee JM; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Cimino-Mathews A; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Peer CJ; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Zimmer A; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Lipkowitz S; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Annunziata CM; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Cao L; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Harrell MI; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Swisher EM; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Houston N; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Botesteanu DA; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Taube JM; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Thompson E; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Ogurtsova A; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Xu H; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Nguyen J; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Ho TW; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Figg WD; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA., Kohn EC; Jung-Min Lee, Cody J. Peer, Alexandra Zimmer, Stanley Lipkowitz, Christina M. Annunziata, Liang Cao, Nicole Houston, Dana-Adriana Botesteanu, Jeffers Nguyen, William D. Figg, and Elise C. Kohn, Center for Cancer Research, National Cancer Institute, Bethesda; Ashley Cimino-Mathews, Janis M. Taube, Elizabeth Thompson, Aleksandra Ogurtsova, and Haiying Xu, The Johns Hopkins Medical Institution, Baltimore; and Tony W. Ho, AstraZeneca, Gaithersburg, MD; and Maria I. Harrell and Elizabeth M. Swisher, University of Washington, Seattle, WA.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2017 Jul 01; Vol. 35 (19), pp. 2193-2202. Date of Electronic Publication: 2017 May 04.

نوع المنشور: Clinical Trial, Phase I; Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*therapeutic use , Genital Neoplasms, Female/*drug therapy, Adult ; Aged ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/pharmacokinetics ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/pharmacokinetics ; B7-H1 Antigen/antagonists & inhibitors ; B7-H1 Antigen/biosynthesis ; B7-H1 Antigen/immunology ; Dose-Response Relationship, Drug ; Female ; Genital Neoplasms, Female/immunology ; Genital Neoplasms, Female/metabolism ; Genital Neoplasms, Female/pathology ; Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; Middle Aged ; Phthalazines/administration & dosage ; Phthalazines/adverse effects ; Phthalazines/pharmacokinetics ; Piperazines/administration & dosage ; Piperazines/adverse effects ; Piperazines/pharmacokinetics ; Poly(ADP-ribose) Polymerase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/administration & dosage ; Protein Kinase Inhibitors/adverse effects ; Quinazolines/administration & dosage ; Quinazolines/adverse effects ; Quinazolines/pharmacokinetics ; Vascular Endothelial Growth Factor Receptor-1/antagonists & inhibitors

المؤلفون: Mishkin G; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States., Minasian LM; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States., Kohn EC; Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States., Noone AM; Division of Cancer Control and Population Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States., Temkin SM; Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, United States. Electronic address: temkinsm@mail.nih.gov.

المصدر: Gynecologic oncology [Gynecol Oncol] 2016 Dec; Vol. 143 (3), pp. 611-616. Date of Electronic Publication: 2016 Sep 30.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Patient Selection*, Clinical Trials as Topic/*statistics & numerical data , Ethnicity/*statistics & numerical data , Genital Neoplasms, Female/*therapy , Insurance, Health/*statistics & numerical data , Medically Uninsured/*statistics & numerical data , Minority Groups/*statistics & numerical data, Adult ; Black or African American/statistics & numerical data ; Age Factors ; Aged ; Female ; Geography ; Hispanic or Latino/statistics & numerical data ; Humans ; Middle Aged ; National Cancer Institute (U.S.) ; Ovarian Neoplasms/therapy ; SEER Program ; United States ; Uterine Cervical Neoplasms/therapy ; Uterine Neoplasms/therapy

المؤلفون: Kristeleit RS; From the Department of Medical Oncology, University College London Hospital, London, United Kingdom; UCL Cancer Institute, University College London, London, United Kingdom; Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Miller RE; From the Department of Medical Oncology, University College London Hospital, London, United Kingdom; UCL Cancer Institute, University College London, London, United Kingdom; Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD., Kohn EC; From the Department of Medical Oncology, University College London Hospital, London, United Kingdom; UCL Cancer Institute, University College London, London, United Kingdom; Clinical Investigations Branch, Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD.

المصدر: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2016; Vol. 35, pp. e259-68.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101233985 Publication Model: Print Cited Medium: Internet ISSN: 1548-8756 (Electronic) Linking ISSN: 15488748 NLM ISO Abbreviation: Am Soc Clin Oncol Educ Book Subsets: MEDLINE

مواضيع طبية MeSH: Molecular Targeted Therapy*, Genital Neoplasms, Female/*drug therapy , Genital Neoplasms, Female/*genetics , Poly(ADP-ribose) Polymerase Inhibitors/*therapeutic use, BRCA1 Protein/genetics ; BRCA2 Protein/genetics ; DNA End-Joining Repair/drug effects ; DNA Mismatch Repair/drug effects ; DNA Repair-Deficiency Disorders/drug therapy ; DNA Repair-Deficiency Disorders/genetics ; Female ; Genital Neoplasms, Female/pathology ; Homologous Recombination/drug effects ; Humans ; Signal Transduction/drug effects

المؤلفون: Lee JM, Ivy SP, Kohn EC

المصدر: Oncology (Williston Park, N.Y.) [Oncology (Williston Park)] 2016 Jan; Vol. 30 (1), pp. 67-9.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MultiMedia Healthcare Country of Publication: United States NLM ID: 8712059 Publication Model: Print Cited Medium: Print ISSN: 0890-9091 (Print) Linking ISSN: 08909091 NLM ISO Abbreviation: Oncology (Williston Park) Subsets: MEDLINE

مواضيع طبية MeSH: Genital Neoplasms, Female/*immunology , Genital Neoplasms, Female/*therapy , Immunotherapy/*methods, Animals ; Female ; Humans ; Immunotherapy/trends

المؤلفون: Azad N; Medical Oncology Branch, Johns Hopkins, 1650 Orleans St., Rm. 4M10, Baltimore, Maryland 21231, USA., Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan A, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC

المصدر: Molecular & cellular proteomics : MCP [Mol Cell Proteomics] 2013 Jun; Vol. 12 (6), pp. 1621-31. Date of Electronic Publication: 2013 Feb 28.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 101125647 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-9484 (Electronic) Linking ISSN: 15359476 NLM ISO Abbreviation: Mol Cell Proteomics Subsets: MEDLINE

مواضيع طبية MeSH: Gene Expression Regulation, Neoplastic*, Antibodies, Monoclonal, Humanized/*therapeutic use , Antineoplastic Agents/*therapeutic use , Biomarkers, Pharmacological/*metabolism , Genital Neoplasms, Female/*diagnosis , Niacinamide/*analogs & derivatives , Phenylurea Compounds/*therapeutic use , Skin Neoplasms/*diagnosis, Adult ; Aged ; Bevacizumab ; Cohort Studies ; Disease Progression ; Drug Administration Schedule ; Drug Therapy, Combination ; Extracellular Signal-Regulated MAP Kinases/genetics ; Extracellular Signal-Regulated MAP Kinases/metabolism ; Female ; Genital Neoplasms, Female/blood supply ; Genital Neoplasms, Female/genetics ; Genital Neoplasms, Female/pathology ; Humans ; Male ; Middle Aged ; Neovascularization, Pathologic ; Niacinamide/therapeutic use ; Nitric Oxide Synthase Type III/genetics ; Nitric Oxide Synthase Type III/metabolism ; Poly(ADP-ribose) Polymerases/genetics ; Poly(ADP-ribose) Polymerases/metabolism ; Predictive Value of Tests ; Proto-Oncogene Proteins c-akt/genetics ; Proto-Oncogene Proteins c-akt/metabolism ; Signal Transduction ; Skin Neoplasms/blood supply ; Skin Neoplasms/genetics ; Skin Neoplasms/pathology ; Sorafenib ; Vascular Endothelial Growth Factor Receptor-2/genetics ; Vascular Endothelial Growth Factor Receptor-2/metabolism

المؤلفون: Kohn EC; Laboratory of Pathology, Gynecologic Malignancies Faculty, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA. ek1b@nih.gov, Mills GB, Liotta L

المصدر: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2003 Oct; Vol. 83 Suppl 1, pp. 203-9.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0210174 Publication Model: Print Cited Medium: Print ISSN: 0020-7292 (Print) Linking ISSN: 00207292 NLM ISO Abbreviation: Int J Gynaecol Obstet Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*analysis , Genital Neoplasms, Female/*diagnosis , Genital Neoplasms, Female/*therapy , Proteomics/*trends, Female ; Humans